![Gregory D. Williams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gregory D. Williams
Consigliere Generale presso Emulate, Inc.
Profilo
Gregory D.
Williams is currently the General Counsel & VP-Corporate Development at Emulate, Inc. Previously, he worked as the General Counsel at New England Biolabs, Inc. He received his undergraduate and graduate degrees from McGill University and his graduate degree from The University of Pennsylvania Law School.
Posizioni attive di Gregory D. Williams
Società | Posizione | Inizio |
---|---|---|
Emulate, Inc.
![]() Emulate, Inc. Drugstore ChainsRetail Trade Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA. | Consigliere Generale | - |
Precedenti posizioni note di Gregory D. Williams
Società | Posizione | Fine |
---|---|---|
New England Biolabs, Inc.
![]() New England Biolabs, Inc. Chemicals: SpecialtyProcess Industries New England Biolabs, Inc. produces and supplies reagents for the life science industry. The firm?s products include restriction endonucleases, PCR, qPCR and amplification technologies, DNA modifying enzymes, sample preparation for next generation sequencing, nucleic acid purification, DNA assembly, cloning and mutagenesis kits, genome editing, competent cells, markers and ladders, RNA reagents, gene expression, cellular analysis, epigenetics, protein tools, DNA plasmids, glycobiology, protein expression and purification technologies. The company was founded by Donald Comb in 1974 and is headquartered in Ipswich, MA. | Consigliere Generale | - |
Formazione di Gregory D. Williams
McGill University | Graduate Degree |
The University of Pennsylvania Law School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
New England Biolabs, Inc.
![]() New England Biolabs, Inc. Chemicals: SpecialtyProcess Industries New England Biolabs, Inc. produces and supplies reagents for the life science industry. The firm?s products include restriction endonucleases, PCR, qPCR and amplification technologies, DNA modifying enzymes, sample preparation for next generation sequencing, nucleic acid purification, DNA assembly, cloning and mutagenesis kits, genome editing, competent cells, markers and ladders, RNA reagents, gene expression, cellular analysis, epigenetics, protein tools, DNA plasmids, glycobiology, protein expression and purification technologies. The company was founded by Donald Comb in 1974 and is headquartered in Ipswich, MA. | Process Industries |
Emulate, Inc.
![]() Emulate, Inc. Drugstore ChainsRetail Trade Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA. | Retail Trade |
- Borsa valori
- Insiders
- Gregory D. Williams